glp-1 alabama Medicaid now covers GLP-1s for obesity in Eli Lilly earmarks $6B for
Description
2033 (USD BILLION) FIGURE 14 GLP-1 AGONISTS MARKET, BY INDICATION, 2025 VS
Other rare but serious side effects linked to Wegovy include pancreatitis and gallbladder problems
Factors CMS will look at include actual prescription utilization, medication costs, patient outcomes, and broader Medicare budget impact
For example, in the STEP 4 trial, participants who stayed on semaglutide for 68 weeks lost an additional 7.9% of their body weight
Regular in-person or in-home follow-up visits with full biometric reassessment
The biggest concern is the disconnect between how intoxicated patients feel and what their alcohol blood level is, says Neha Agrawal, Director of Clinical Pharmacy Services at Legacy Community Health
